Letters
Volume 31—2025
Volume 30—2024
Volume 29—2023
Volume 28—2022
Volume 27—2021
Volume 26—2020
Volume 25—2019
Volume 24—2018
Volume 23—2017
Volume 22—2016
Volume 21—2015
Volume 30—2024
Volume 29—2023
Volume 28—2022
Volume 27—2021
Volume 26—2020
Volume 25—2019
Volume 24—2018
Volume 23—2017
Volume 22—2016
Volume 21—2015
Volume 25—2019
Volume 25, Number 11—November 2019
Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014 [PDF - 344 KB - 2 pages]
| EID | Amoureux L, Bador J, Neuwirth C. Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014. Emerg Infect Dis. 2019;25(11):2158-2159. https://doi.org/10.3201/eid2511.161487 |
|---|---|
| AMA | Amoureux L, Bador J, Neuwirth C. Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014. Emerging Infectious Diseases. 2019;25(11):2158-2159. doi:10.3201/eid2511.161487. |
| APA | Amoureux, L., Bador, J., & Neuwirth, C. (2019). Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014. Emerging Infectious Diseases, 25(11), 2158-2159. https://doi.org/10.3201/eid2511.161487. |
Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017 [PDF - 786 KB - 2 pages]
| EID | Adelantado M, Navascués A, Beristain X, Gil-Setas A, Portillo ME, Aguinaga A, et al. Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017. Emerg Infect Dis. 2019;25(11):2159-2160. https://doi.org/10.3201/eid2511.190912 |
|---|---|
| AMA | Adelantado M, Navascués A, Beristain X, et al. Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017. Emerging Infectious Diseases. 2019;25(11):2159-2160. doi:10.3201/eid2511.190912. |
| APA | Adelantado, M., Navascués, A., Beristain, X., Gil-Setas, A., Portillo, M. E., Aguinaga, A....Ezpeleta, C. (2019). Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017. Emerging Infectious Diseases, 25(11), 2159-2160. https://doi.org/10.3201/eid2511.190912. |
Volume 25, Number 10—October 2019
Databases for Research and Development [PDF - 287 KB - 1 page]
| EID | Head MG. Databases for Research and Development. Emerg Infect Dis. 2019;25(10):1996. https://doi.org/10.3201/eid2510.181411 |
|---|---|
| AMA | Head MG. Databases for Research and Development. Emerging Infectious Diseases. 2019;25(10):1996. doi:10.3201/eid2510.181411. |
| APA | Head, M. G. (2019). Databases for Research and Development. Emerging Infectious Diseases, 25(10), 1996. https://doi.org/10.3201/eid2510.181411. |
Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 Transmission [PDF - 534 KB - 2 pages]
| EID | Styles CE, Hoad VC, Denham-Ricks P, Brown D, Seed CR. Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 Transmission. Emerg Infect Dis. 2019;25(10):1996-1997. https://doi.org/10.3201/eid2510.190484 |
|---|---|
| AMA | Styles CE, Hoad VC, Denham-Ricks P, et al. Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 Transmission. Emerging Infectious Diseases. 2019;25(10):1996-1997. doi:10.3201/eid2510.190484. |
| APA | Styles, C. E., Hoad, V. C., Denham-Ricks, P., Brown, D., & Seed, C. R. (2019). Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 Transmission. Emerging Infectious Diseases, 25(10), 1996-1997. https://doi.org/10.3201/eid2510.190484. |
Volume 25, Number 7—July 2019
Nontoxigenic Corynebacterium diphtheriae Infections, Europe [PDF - 355 KB - 2 pages]
| EID | Zasada AA, Rzeczkowska M. Nontoxigenic Corynebacterium diphtheriae Infections, Europe. Emerg Infect Dis. 2019;25(7):1437-1438. https://doi.org/10.3201/eid2507.180995 |
|---|---|
| AMA | Zasada AA, Rzeczkowska M. Nontoxigenic Corynebacterium diphtheriae Infections, Europe. Emerging Infectious Diseases. 2019;25(7):1437-1438. doi:10.3201/eid2507.180995. |
| APA | Zasada, A. A., & Rzeczkowska, M. (2019). Nontoxigenic Corynebacterium diphtheriae Infections, Europe. Emerging Infectious Diseases, 25(7), 1437-1438. https://doi.org/10.3201/eid2507.180995. |
Racial/Ethnic Disparities in Antimicrobial Drug Use, United States, 2014–2015 [PDF - 313 KB - 1 page]
| EID | Thomas M, Whyler N, Tomlin A, Tilyard M. Racial/Ethnic Disparities in Antimicrobial Drug Use, United States, 2014–2015. Emerg Infect Dis. 2019;25(7):1438. https://doi.org/10.3201/eid2507.181775 |
|---|---|
| AMA | Thomas M, Whyler N, Tomlin A, et al. Racial/Ethnic Disparities in Antimicrobial Drug Use, United States, 2014–2015. Emerging Infectious Diseases. 2019;25(7):1438. doi:10.3201/eid2507.181775. |
| APA | Thomas, M., Whyler, N., Tomlin, A., & Tilyard, M. (2019). Racial/Ethnic Disparities in Antimicrobial Drug Use, United States, 2014–2015. Emerging Infectious Diseases, 25(7), 1438. https://doi.org/10.3201/eid2507.181775. |
Volume 25, Number 2—February 2019
Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas [PDF - 546 KB - 2 pages]
| EID | Sharma G, Sharma V. Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas. Emerg Infect Dis. 2019;25(2):389-390. https://doi.org/10.3201/eid2502.171895 |
|---|---|
| AMA | Sharma G, Sharma V. Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas. Emerging Infectious Diseases. 2019;25(2):389-390. doi:10.3201/eid2502.171895. |
| APA | Sharma, G., & Sharma, V. (2019). Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas. Emerging Infectious Diseases, 25(2), 389-390. https://doi.org/10.3201/eid2502.171895. |
Page created: January 18, 2019
Page updated: October 16, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
